Stock BAX BAXTER INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Baxter International Inc. Wiener Boerse

Equities

BAX

US0718131099

End-of-day quote Wiener Boerse
Other stock markets
 23:00:00 16/06/2024 BST 		5-day change 1st Jan Change
31.52 EUR +0.16% Intraday chart for Baxter International Inc. +2.62% -10.20%
06-20 Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors CI
06-12 Transcript : Baxter International Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors
EE.UU. - Valores a seguir en Wall Street (actualizado)
Baxter International Inc. Announces New Data Showing Expanded Hemodialysis, Known as HDX Therapy
Baxter International's Clinolipid Injection Approved for Expanded Use in US
Baxter International Inc. Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
Baxter International Inc. Declares Quarterly Dividend, Payable on July 1, 2024
Baxter International Q1 Adjusted Earnings, Net Sales Gain; Boosts 2024 Adjusted Profit Guidance
Baxter International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Baxter International Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024
WOCHENVORSCHAU: Termine bis 10. Mai 2024
Edwards Lifesciences Corporation: het verhaal gaat verder
Edwards Lifesciences Corporation : La historia continúa
Edwards Lifesciences Corporation: Fortlaufende Erfolgsgeschichte
Edwards Lifesciences Corporation: la storia continua
Edwards Lifesciences Corporation : L’histoire se poursuit
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period
Baxter International Receives US FDA Clearance for Novum IQ Large Volume Infusion Pump
Baxter International Inc. Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
Baxter International Receives a Shareholder Proposal from John Chevedden
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAX Stock
  4. BAX Stock
  5. News Baxter International Inc.
  6. Other languages